JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackhart, BrianD.
Right arrow Articles by Scarborough, RobertM.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackhart, BrianD.
Right arrow Articles by Scarborough, RobertM.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 28, Issue of July 12, 1996 pp. 16466-16471
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Ligand Cross-reactivity within the Protease-activated Receptor Family

(Received for publication, March 28, 1996)

Brian D. Blackhart Dagger , Kjell Emilsson , Dat Nguyen Dagger , Willy Teng Dagger , Arnold J. Martelli Dagger , Sverker Nystedt , Johan Sundelin and Robert M. Scarborough Dagger

From Dagger  COR Therapeutics, Inc., South San Francisco, California 94080 and the  Division of Molecular Neurobiology, The Wallenberg Laboratory, Lund University, S-220 07 Lund, Sweden

Recently, a second member of the protease-activated receptor (PAR) family, named PAR-2, has been identified. Similar to the thrombin receptor, PAR-2 appears to be activated by proteolytic-mediated exposure of a ``tethered ligand'' sequence and can also be activated by the corresponding synthetic peptides. Similarities in the amino acid sequence of the receptors' tethered ligand sequences suggest that their respective agonist peptides might not be absolutely specific for their particular receptors. To test this, the receptor specificity of each agonist has been determined by measuring the responses of Xenopus oocytes expressing the thrombin receptor or PAR-2 to agonist peptides or enzymes. Thrombin receptors responded to thrombin, the human thrombin receptor-activating peptide SFLLRNP-NH2 (TRAP) (EC50 = 0.1 µM), and Xenopus TRAP, TFRIFD-NH2 (EC50 = 1 µM), but did not show any increase in calcium efflux over control levels with trypsin (50 nM) or PAR-2 agonist peptides (100 µM). Human and murine PAR-2 receptors responded comparably to human and murine PAR-2 agonist peptides (SLIGKVD and SLIGRL, respectively) (EC50 = 0.5-2.0 µM) and trypsin, but not to thrombin. PAR-2 was also found to be responsive to TRAP (EC50 = 1 µM) but was unresponsive to Xenopus TRAP (50 µM). Responses to additional peptide agonist analogs suggest that an amino-terminal serine is critical for PAR-2 agonist activity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Li, T. Syrovets, S. Paskas, Y. Laumonnier, and T. Simmet
Mature Dendritic Cells Express Functional Thrombin Receptors Triggering Chemotaxis and CCL18/Pulmonary and Activation-Regulated Chemokine Induction
J. Immunol., July 15, 2008; 181(2): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Shpacovitch, M. Feld, M. D. Hollenberg, T. A. Luger, and M. Steinhoff
Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity
J. Leukoc. Biol., June 1, 2008; 83(6): 1309 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Jiang, A. Zatta, H. Kin, N. Wang, J. G. Reeves, J. Mykytenko, J. Deneve, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen
PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2845 - H2852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Bengrine, J. Li, L. L. Hamm, and M. S. Awayda
Indirect Activation of the Epithelial Na+ Channel by Trypsin
J. Biol. Chem., September 14, 2007; 282(37): 26884 - 26896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Knecht, G. S. Cottrell, S. Amadesi, J. Mohlin, A. Skaregarde, K. Gedda, A. Peterson, K. Chapman, M. D. Hollenberg, N. Vergnolle, et al.
Trypsin IV or Mesotrypsin and p23 Cleave Protease-activated Receptors 1 and 2 to Induce Inflammation and Hyperalgesia
J. Biol. Chem., September 7, 2007; 282(36): 26089 - 26100.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. G. Kirkland, G. S. Cottrell, N. W. Bunnett, and C. U. Corvera
Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G335 - G346.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. H. Cleator, W. Q. Zhu, D. E. Vaughan, and H. E. Hamm
Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP
Blood, April 1, 2006; 107(7): 2736 - 2744.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. B. Kelso, J. C. Lockhart, T. Hembrough, L. Dunning, R. Plevin, M. D. Hollenberg, C. P. Sommerhoff, J. S. McLean, and W. R. Ferrell
Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1017 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, L. Shen, M. Holinstat, J. D. Brooks, E. DiBenedetto, and H. E. Hamm
Functional Selectivity of G Protein Signaling by Agonist Peptides and Thrombin for the Protease-activated Receptor-1
J. Biol. Chem., July 1, 2005; 280(26): 25048 - 25059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, M. R. Mazzoni, J. H. Cleator, L. Earls, A. L. Perdigoto, J. D. Brooks, J. A. S. Muldowney III, D. E. Vaughan, and H. E. Hamm
Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells
J. Biol. Chem., June 10, 2005; 280(23): 22172 - 22180.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
Endocr. Rev., February 1, 2005; 26(1): 1 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Tanaka, T. Morita, A. Nezu, A. Tanimura, I. Mizoguchi, and Y. Tojyo
Signaling Mechanisms Involved in Protease-Activated Receptor-1-Mediated Interleukin-6 Production by Human Gingival Fibroblasts
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 778 - 786.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Koetzner, J. A. Gregory, and T. L. Yaksh
Intrathecal Protease-Activated Receptor Stimulation Produces Thermal Hyperalgesia through Spinal Cyclooxygenase Activity
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 356 - 363.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
X. Shi, B. Gangadharan, L. F. Brass, W. Ruf, and B. M. Mueller
Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis
Mol. Cancer Res., July 1, 2004; 2(7): 395 - 402.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. S. OSSOVSKAYA and N. W. BUNNETT
Protease-Activated Receptors: Contribution to Physiology and Disease
Physiol Rev, April 1, 2004; 84(2): 579 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. J. Bolton, C. A. McNulty, R. J. Thomas, C. R. A. Hewitt, and A. J. Wardlaw
Expression of and functional responses to protease-activated receptors on human eosinophils
J. Leukoc. Biol., July 1, 2003; 74(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. L. Copple, F. Moulin, U. M. Hanumegowda, P. E. Ganey, and R. A. Roth
Thrombin and Protease-Activated Receptor-1 Agonists Promote Lipopolysaccharide-Induced Hepatocellular Injury in Perfused Livers
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 417 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. McGuire, J. Dai, P. Andrade-Gordon, C. R. Triggle, and M. D. Hollenberg
Proteinase-Activated Receptor-2 (PAR2): Vascular Effects of a PAR2-Derived Activating Peptide via a Receptor Different than PAR2
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 985 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Asokananthan, P. T. Graham, D. J. Stewart, A. J. Bakker, K. A. Eidne, P. J. Thompson, and G. A. Stewart
House Dust Mite Allergens Induce Proinflammatory Cytokines from Respiratory Epithelial Cells: The Cysteine Protease Allergen, Der p 1, Activates Protease-Activated Receptor (PAR)-2 and Inactivates PAR-1
J. Immunol., October 15, 2002; 169(8): 4572 - 4578.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Vergnolle, C. K. Derian, M. R. D'Andrea, M. Steinhoff, and P. Andrade-Gordon
Characterization of Thrombin-Induced Leukocyte Rolling and Adherence: A Potential Proinflammatory Role for Proteinase-Activated Receptor-4
J. Immunol., August 1, 2002; 169(3): 1467 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. D. Hollenberg and S. J. Compton
International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors
Pharmacol. Rev., June 1, 2002; 54(2): 203 - 217.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Asokananthan, P. T. Graham, J. Fink, D. A. Knight, A. J. Bakker, A. S. McWilliam, P. J. Thompson, and G. A. Stewart
Activation of Protease-Activated Receptor (PAR)-1, PAR-2, and PAR-4 Stimulates IL-6, IL-8, and Prostaglandin E2 Release from Human Respiratory Epithelial Cells
J. Immunol., April 1, 2002; 168(7): 3577 - 3585.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Al-Ani, M. Saifeddine, S. J. Wijesuriya, and M. D. Hollenberg
Modified Proteinase-Activated Receptor-1 and -2 Derived Peptides Inhibit Proteinase-Activated Receptor-2 Activation by Trypsin
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 702 - 708.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. SCHMIDLIN, S. AMADESI, R. VIDIL, M. TREVISANI, N. MARTINET, G. CAUGHEY, M. TOGNETTO, G. CAVALLESCO, C. MAPP, P. GEPPETTI, et al.
Expression and Function of Proteinase-activated Receptor 2 in Human Bronchial Smooth Muscle
Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1276 - 1281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Sun, M. A. Stacey, M. Schmidt, L. Mori, and S. Mattoli
Interaction of Mite Allergens Der P3 and Der P9 with Protease-Activated Receptor-2 Expressed by Lung Epithelial Cells
J. Immunol., July 15, 2001; 167(2): 1014 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin
Proteinase-Activated Receptors
Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. D. Blackhart, L. Ruslim-Litrus, C.-C. Lu, V. L. Alves, W. Teng, R. M. Scarborough, E. E. Reynolds, and D. Oksenberg
Extracellular Mutations of Protease-Activated Receptor-1 Result in Differential Activation by Thrombin and Thrombin Receptor Agonist Peptide
Mol. Pharmacol., April 13, 2001; 58(6): 1178 - 1187.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Bono, P. Schaeffer, J.-P. Herault, C. Michaux, A.-L. Nestor, J.-C. Guillemot, and J.-M. Herbert
Factor Xa Activates Endothelial Cells by a Receptor Cascade Between EPR-1 and PAR-2
Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20 (11): e107 - e112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. O'Brien, N. Prevost, M. Molino, M. K. Hollinger, M. J. Woolkalis, D. S. Woulfe, and L. F. Brass
Thrombin Responses in Human Endothelial Cells. CONTRIBUTIONS FROM RECEPTORS OTHER THAN PAR1 INCLUDE THE TRANSACTIVATION OF PAR2 BY THROMBIN-CLEAVED PAR1
J. Biol. Chem., April 28, 2000; 275(18): 13502 - 13509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-Q. Huang, J.-J. Li, and S. Karpatkin
Thrombin Inhibits Tumor Cell Growth in Association with Up-regulation of p21waf/cip1 and Caspases via a p53-independent, STAT-1-dependent Pathway
J. Biol. Chem., February 25, 2000; 275(9): 6462 - 6468.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C Chinni, M. de Niese, A. Jenkins, R. Pike, S. Bottomley, and E. Mackie
Protease-activated receptor-2 mediates proliferative responses in skeletal myoblasts
J. Cell Sci., January 12, 2000; 113(24): 4427 - 4433.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. A. Akers, M. Parsons, M. R. Hill, M. D. Hollenberg, S. Sanjar, G. J. Laurent, and R. J. McAnulty
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L193 - L201.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Al-Ani, M. Saifeddine, A. Kawabata, B. Renaux, S. Mokashi, and M. D. Hollenberg
Proteinase-Activated Receptor 2 (PAR2): Development of a Ligand-Binding Assay Correlating with Activation of PAR2 by PAR1- and PAR2-Derived Peptide Ligands
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 753 - 760.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
B. P. Damiano, W.-M. Cheung, R. J. Santulli, W.-P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. de Garavilla, and P. Andrade-Gordon
Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 671 - 678.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kawabata, M. Saifeddine, B. Al-Ani, L. Leblond, and M. D. Hollenberg
Evaluation of Proteinase-Activated Receptor-1 (PAR1) Agonists and Antagonists Using a Cultured Cell Receptor Desensitization Assay: Activation of PAR2 by PAR1-Targeted Ligands
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 358 - 370.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
J. R. Hamilton, P. B. Nguyen, and T. M. Cocks
Atypical Protease-Activated Receptor Mediates Endothelium-Dependent Relaxation of Human Coronary Arteries
Circ. Res., June 29, 1998; 82(12): 1306 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Vergnolle, W. K. Macnaughton, B. Al-Ani, M. Saifeddine, J. L. Wallace, and M. D. Hollenberg
Proteinase-activated receptor 2 (PAR2)-activating peptides: Identification of a receptor distinct from PAR2 that regulates intestinal transport
PNAS, June 23, 1998; 95(13): 7766 - 7771.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. Dery, C. U. Corvera, M. Steinhoff, and N. W. Bunnett
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1429 - C1452.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Molino, P. N. Raghunath, A. Kuo, M. Ahuja, J. A. Hoxie, L. F. Brass, and E. S. Barnathan
Differential Expression of Functional Protease-Activated Receptor-2 (PAR-2) in Human Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 825 - 832.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-L. Zheng, B. Renaux, and M. D. Hollenberg
Parallel Contractile Signal Transduction Pathways Activated by Receptors for Thrombin and Epidermal Growth Factor-Urogastrone in Guinea Pig Gastric Smooth Muscle: Blockade by Inhibitors of Mitogen-Activated Protein Kinase-Kinase and Phosphatidyl Inositol 3'-Kinase
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 325 - 334.
[Abstract] [Full Text]


Home page
BloodHome page
H. Mirza, V. A. Schmidt, C. K. Derian, J. Jesty, and W. F. Bahou
Mitogenic Responses Mediated Through the Proteinase-Activated Receptor-2 Are Induced by Expressed Forms of Mast Cell alpha - or beta -Tryptases
Blood, November 15, 1997; 90(10): 3914 - 3922.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. E. Joyce, Y. Chen, R. A. Erger, G. A. Koretzky, and S. R. Lentz
Functional Interactions Between the Thrombin Receptor and the T-Cell Antigen Receptor in Human T-Cell Lines
Blood, September 1, 1997; 90(5): 1893 - 1901.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Kong, K. McConalogue, L. M. Khitin, M. D. Hollenberg, D. G. Payan, S. K. Bohm, and N. W. Bunnett
Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
PNAS, August 5, 1997; 94(16): 8884 - 8889.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. M. Donovan, C. J. Pike, C. W. Cotman, and D. D. Cunningham
Thrombin Induces Apoptosis in Cultured Neurons and Astrocytes via a Pathway Requiring Tyrosine Kinase and RhoA Activities
J. Neurosci., July 15, 1997; 17(14): 5316 - 5326.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Molino, M. J. Woolkalis, J. Reavey-Cantwell, D. Pratico, P. Andrade-Gordon, E. S. Barnathan, and L. F. Brass
Endothelial Cell Thrombin Receptors and PAR-2. TWO PROTEASE-ACTIVATED RECEPTORS LOCATED IN A SINGLE CELLULAR ENVIRONMENT
J. Biol. Chem., April 25, 1997; 272(17): 11133 - 11141.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Renesto, M. Si-Tahar, M. Moniatte, V. Balloy, A. Van Dorsselaer, D. Pidard, and M. Chignard
Specific Inhibition of Thrombin-Induced Cell Activation by the Neutrophil Proteinases Elastase, Cathepsin G, and Proteinase 3: Evidence for Distinct Cleavage Sites Within the Aminoterminal Domain of the Thrombin Receptor
Blood, March 15, 1997; 89(6): 1944 - 1953.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Molino, E. S. Barnathan, R. Numerof, J. Clark, M. Dreyer, A. Cumashi, J. A. Hoxie, N. Schechter, M. Woolkalis, and L. F. Brass
Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2
J. Biol. Chem., February 14, 1997; 272(7): 4043 - 4049.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Howells, M. Macey, C Chinni, L Hou, M. Fox, P Harriott, and S. Stone
Proteinase-activated receptor-2: expression by human neutrophils
J. Cell Sci., January 4, 1997; 110(7): 881 - 887.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Compton, J. A. Cairns, K.-J. Palmer, B. Al-Ani, M. D. Hollenberg, and A. F. Walls
A Polymorphic Protease-activated Receptor 2 (PAR2) Displaying Reduced Sensitivity to Trypsin and Differential Responses to PAR Agonists
J. Biol. Chem., December 8, 2000; 275(50): 39207 - 39212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.